
    
      When the patients can be roused, they will first receive analgesia with bolus of fentanyl
      0.03mg, followed by a continuous infusion at a ﬁxed dose of 0.3μg/kg/h during study period.
      Then patients will be randomly divided into two groups (Dexmedetomidine and Propofol). All of
      them will receive hemodynamic monitoring through "Vigileo"(Edwards Lifesciences) and
      cardiogram monitor. The study will continue for 6-24 hours.
    
  